Merck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase – Still a Buy?

Merck KGaA (OTCMKTS:MKGAFGet Free Report) shares saw unusually-strong trading volume on Monday . Approximately 2,270 shares changed hands during mid-day trading, an increase of 482% from the previous session’s volume of 390 shares.The stock last traded at $152.76 and had previously closed at $152.25.

Merck KGaA Price Performance

The stock has a fifty day moving average of $143.41 and a 200-day moving average of $135.58. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $19.79 billion, a price-to-earnings ratio of 23.38 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Further Reading

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.